Scholars Central

Conference abstractPublished 2019

Change of the 2008/16 WHO into 2018 clinical, laboratory, molecular and pathobiological (WHO-CLMP) criteria for diagnosis of the meloproliferative neoplasms JAK2V617F trilinear polycythemia vera (PV), JAK2 exon 12 PV and JAK2V617F, CALR or MPL515 mutated thrombocythemias and secondary myelofibrosis

Authors: Jan Jacques Michiels

Journal of Medical Oncology and Therapeutics

Issue proc-oncology-cancer-therapy-2019

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Medical Oncology and Therapeutics
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jan Jacques Michiels”